We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Takeda Pharmaceutical Co., Ltd. announced today that it has published in the blood about refractory chronic myelogenous leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia.